Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
about
Identification of the plasma metabolomics as early diagnostic markers between biliary atresia and neonatal hepatitis syndromeRapidly improved determination of metabolites from biological data sets using the high-efficient TransOmics tool.A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumorsMetabolomics in the fight against malaria.Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyUrinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicityMulti-step preparation technique to recover multiple metabolite compound classes for in-depth and informative metabolomic analysis.Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system.Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.Metabolomic analysis of diet-induced type 2 diabetes using UPLC/MS integrated with pattern recognition approachMolecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric FabVasorin is a potential serum biomarker and drug target of hepatocarcinoma screened by subtractive-EMSA-SELEX to clinic patient serum.Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics ApproachChromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews.Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinomaA review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samplesDissection of Biological Property of Chinese Acupuncture Point Zusanli Based on Long-Term Treatment via Modulating Multiple Metabolic Pathways.Cell metabolomics.Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assayDown-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinomaPrecision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.Proteomics progresses in microbial physiology and clinical antimicrobial therapy.Ablation of hepatic malignant tumors with irreversible electroporation: A systematic review and meta-analysis of outcomesSeveral microRNAs could predict survival in patients with hepatitis B-related liver cancer.Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylationRecent advances in metabolomics in neurological disease, and future perspectives.NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.Metabolomics insights into pathophysiological mechanisms of nephrology.Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks.High resolution metabolomics technology reveals widespread pathway changes of alcoholic liver disease.Current Trends and Innovations in Bioanalytical Techniques of Metabolomics.NMR metabolomics of renal cancer: an overview.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.
P2860
Q28538533-0FEB9358-D8FF-47AE-8880-BC84142F8E40Q30828421-1639D53A-7147-4BB3-A992-0AAAE7CF3DFFQ33638900-16F6620F-2AEE-494C-B206-585D53A12F27Q33916237-16420BD8-99E2-4ABA-9A9B-16BF264E02DAQ34142744-0C6ECDE0-D95F-4560-BED9-4F661A3D69B0Q34256150-9E7E841C-3BD2-46E6-9781-1FB0E18BC4CCQ34397065-BFC2A09A-C8EC-421B-8402-8F8CCDBC1DCDQ34426998-8FF91A3C-2756-46C2-8774-5013D5FD8FDDQ34734170-4B3D8609-911D-43C3-840F-AE3C8E50CD5AQ34944763-1F0A2099-15E6-4F14-9654-4BE34EA75D89Q35132184-C4A5A558-DC46-4BB8-8207-11C73F1FFDCDQ35662815-35433EDE-7810-4509-A492-E8DB9C2DE1FEQ35832909-DBDFD7D9-7AF8-46D0-BD0C-97D3D37071ACQ35902748-75A9D11E-0125-46D0-99DD-16D1BEF15E90Q36197829-08A9E768-D92F-42E0-BE7F-7A5B6C8F0624Q36360941-4579A80B-8D60-4829-A7E5-AA908D8F43A6Q36666366-3AFB11E8-41DB-4772-98BA-BCDA7DC17D1EQ36932065-12669D1B-8355-4493-BCCB-7C41E928682BQ37031700-63CF8086-95C0-4C51-AF8A-F9E27E8CFC02Q37109693-937C576C-FBE7-4C0E-A7AF-7A596B361EA9Q37131903-2E8025A5-21B3-43D3-A8FC-D542D3E1129DQ37173518-33F3815C-CF0C-4D21-A016-EBD853A7FD43Q37199564-3BDEC942-B06F-467B-B172-E04955F1A139Q37303512-8869C0ED-09CD-45FE-B071-4B1FE7737C07Q37349092-C58BE7CE-A4A7-4C39-9492-B41E2B693D1BQ37568560-DBAB6018-3F6F-48B0-9BC2-B5D15D80CA66Q37642133-A81EB452-AF77-4E4D-AB83-7C1A8B4B6468Q37701497-15B05D4F-5FC2-4802-B33B-55A63C8A932BQ37713066-0AC40759-ADE1-49D7-8A71-AB1282ED11BAQ37716553-ACB70790-1A4F-4DE2-8BEF-2CBC24D76F4CQ38110171-F690244F-860E-43E6-934D-8FED3EC2E5EAQ38119451-3044A074-0608-46CD-9599-229957504D02Q38161822-6B7C2E21-85EB-4AA6-AC9D-E3B675FA81BFQ38217062-E95D2F80-9B3D-4B95-9544-6E3B36C9F2B3Q38366584-6E2FFDB7-2F4C-446F-934B-A4B9DD2E9D2EQ38436698-55675B22-EB58-454F-A576-F9C9C5CF305AQ38454397-DD1FBB7F-EEAD-4E52-BFDF-014558F979E1Q38580222-80AD4E92-0739-4766-B532-272B697041FEQ38591205-0E74F777-DB89-4798-9299-185B3CA10328Q38635611-47004394-71C6-4C29-99E7-FF5148FCC33C
P2860
Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
@en
type
label
Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
@en
prefLabel
Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1002/HEP.26130
P407
P577
2013-02-15T00:00:00Z